» Articles » PMID: 33317050

Adiponectin in Chronic Kidney Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Dec 15
PMID 33317050
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Adiponectin is the adipokine associated with insulin sensitization, reducing liver gluconeogenesis, and increasing fatty acid oxidation and glucose uptake. Adiponectin is present in the kidneys, mainly in the arterial endothelium and smooth muscle cells, as well as in the capillary endothelium, and might be considered as a marker of many negative factors in chronic kidney disease. The last few years have brought a rising body of evidence that adiponectin is a multipotential protein with anti-inflammatory, metabolic, anti-atherogenic, and reactive oxygen species (ROS) protective actions. Similarly, adiponectin has shown many positive and direct actions in kidney diseases, and among many kidney cells. Data from large cross-sectional and cohort studies showed a positive correlation between serum adiponectin and mortality in chronic kidney disease. This suggests a complex interaction between local adiponectin action, comorbidities, and uremic milieu. In this review we discuss the role of adiponectin in chronic kidney disease.

Citing Articles

Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target.

Milani I, Codini M, Guarisco G, Chinucci M, Gaita C, Leonetti F Int J Mol Sci. 2024; 25(19).

PMID: 39409124 PMC: 11477334. DOI: 10.3390/ijms251910795.


Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases.

Hemat Jouy S, Mohan S, Scichilone G, Mostafa A, Mahmoud A Biomedicines. 2024; 12(9).

PMID: 39335642 PMC: 11428859. DOI: 10.3390/biomedicines12092129.


Soy Supplementation Does Not Affect Serum Adiponectin Levels in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Karimian J, Shekarchizadeh-Esfahani P Clin Nutr Res. 2024; 13(2):130-138.

PMID: 38784852 PMC: 11109928. DOI: 10.7762/cnr.2024.13.2.130.


The New Challenge of Obesity - Obesity-Associated Nephropathy.

Hao M, Lv Y, Liu S, Guo W Diabetes Metab Syndr Obes. 2024; 17:1957-1971.

PMID: 38737387 PMC: 11086398. DOI: 10.2147/DMSO.S433649.


Exploring Adiponectin in Autosomal Dominant Kidney Disease: Insight and Implications.

Nigro E, Mallardo M, Amicone M, DArco D, Riccio E, Marra M Genes (Basel). 2024; 15(4).

PMID: 38674417 PMC: 11050174. DOI: 10.3390/genes15040484.


References
1.
Clark J, Taylor C, Zahradka P . Exploring the Cardio-metabolic Relevance of T-cadherin: A Pleiotropic Adiponectin Receptor. Endocr Metab Immune Disord Drug Targets. 2017; 17(3):200-206. DOI: 10.2174/1871530317666170818120224. View

2.
Decleves A, Mathew A, Cunard R, Sharma K . AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol. 2011; 22(10):1846-55. PMC: 3187184. DOI: 10.1681/ASN.2011010026. View

3.
Sakura T, Okuno S, Nishio E, Norimine K, Ishimura E, Yamakawa T . The association of serum adiponectin with abdominal aortic calcification in Japanese male hemodialysis patients: a cross-sectional observational study. Sci Rep. 2017; 7(1):6434. PMC: 5526980. DOI: 10.1038/s41598-017-06850-4. View

4.
Lo M, Mitsnefes M . Adiponectin, cardiovascular disease, chronic kidney disease: emerging data on complex interactions. Pediatr Nephrol. 2011; 27(4):521-7. DOI: 10.1007/s00467-011-1804-2. View

5.
Yamakado S, Cho H, Inada M, Morikawa M, Jiang Y, Saito K . Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy. BMJ Open Diabetes Res Care. 2019; 7(1):e000661. PMC: 6557464. DOI: 10.1136/bmjdrc-2019-000661. View